Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-27
DOI
10.1038/s41419-022-05350-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer
- (2022) Chenglin Li et al. ACS Applied Materials & Interfaces
- Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
- (2022) Souvick Roy et al. Molecular Cancer
- Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
- (2022) Adriana Carneiro et al. Cells
- Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
- (2022) Liubing Hu et al. Frontiers in Oncology
- Current treatment and recent progress in gastric cancer
- (2021) Smita S. Joshi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer
- (2021) Daisuke Matsushita et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication
- (2021) Jun Hou et al. Molecular Cancer
- Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer
- (2021) Hyun Mu Shin et al. Nature Communications
- Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer
- (2021) Kazuhide Ko et al. Cancer Medicine
- The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer
- (2021) Isamu Hoshino International Journal of Clinical Oncology
- The role and application of small extracellular vesicles in gastric cancer
- (2021) Hao Wu et al. Molecular Cancer
- TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
- (2021) Jia Li et al. PeerJ
- Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
- (2021) Tomoko Jogo et al. CLINICAL CANCER RESEARCH
- EpiPanGI Dx: A cell-free DNA methylation fingerprint for the early detection of gastrointestinal cancers
- (2021) Raju Kandimalla et al. CLINICAL CANCER RESEARCH
- Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer
- (2021) Xuan‐Yu Hu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
- (2021) Misako Nagasaka et al. Molecular Cancer
- Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
- (2021) Yang Chen et al. Human Cell
- Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients
- (2021) Chengcheng Qian et al. Frontiers in Oncology
- Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients
- (2021) Jie Ren et al. CLINICAL CHEMISTRY
- Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy
- (2021) Yaopeng Qiu et al. EJSO
- Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study
- (2021) Joon Hyung Jhi et al. Journal of Clinical Medicine
- Evaluating the presence of deregulated tumoral onco-microRNAs in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers
- (2021) Houman Kahroba et al. BioImpacts
- Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
- (2020) Huiyan Luo et al. Science Translational Medicine
- Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
- (2020) Jie Sun et al. Journal for ImmunoTherapy of Cancer
- Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
- (2020) Elaine Kilgour et al. CANCER CELL
- Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
- (2020) Jian Yang et al. Cell Death & Disease
- Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
- (2020) Yuejiao Zhong et al. Cancer Management and Research
- Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer
- (2020) Eizaburou Hideura et al. Cancers
- Prognostic Significance of Circulating Tumor Cells with Mesenchymal Phenotypes in Patients with Gastric Cancer: A Prospective Study
- (2020) Yui Ishiguro et al. ANNALS OF SURGICAL ONCOLOGY
- Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
- (2020) Mark R. Openshaw et al. BRITISH JOURNAL OF CANCER
- Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
- (2020) Jiaping Li et al. Journal of Translational Medicine
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
- (2020) Pier Vitale Nuzzo et al. NATURE MEDICINE
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Value of Plasma Methylated SFRP2 in Prognosis of Gastric Cancer
- (2020) Haijiao Yan et al. DIGESTIVE DISEASES AND SCIENCES
- The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer
- (2020) María Alarcón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
- (2020) Yuichiro Miki et al. Cancer Medicine
- Screening for Gastric Cancer: Focus on the Ants Instead of the Ant Hill
- (2020) Mimi C. Tan et al. Clinical Gastroenterology and Hepatology
- The role of exosomal noncoding RNAs in cancer
- (2019) Yan Xie et al. Molecular Cancer
- Tumor-educated platelets
- (2019) Sjors G.J.G. In 't Veld et al. BLOOD
- Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
- (2019) Yibo Fan et al. ANNALS OF SURGICAL ONCOLOGY
- Exosomes
- (2019) D. Michiel Pegtel et al. Annual Review of Biochemistry
- A novel urinary microRNA biomarker panel for detecting gastric cancer
- (2019) Hiroyasu Iwasaki et al. JOURNAL OF GASTROENTEROLOGY
- Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
- (2019) Qianwei Ye et al. Molecular Cancer
- Gastric cancer: Translating novels concepts into clinical practice
- (2019) Massimiliano Salati et al. CANCER TREATMENT REVIEWS
- Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA
- (2019) Shu Yi Shen et al. Nature Protocols
- Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
- (2019) Zuhua Chen et al. Cell Death & Disease
- Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
- (2018) S T Kim et al. ANNALS OF ONCOLOGY
- Circulating tumor cell isolation, culture, and downstream molecular analysis
- (2018) Sandhya Sharma et al. BIOTECHNOLOGY ADVANCES
- HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
- (2018) Haixing Wang et al. EUROPEAN JOURNAL OF CANCER
- Liquid biomarkers in melanoma: detection and discovery
- (2018) Su Yin Lim et al. Molecular Cancer
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis
- (2018) Chaogang Yang et al. OncoTargets and Therapy
- Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer
- (2018) Feng Li et al. CLINICAL CHEMISTRY
- CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
- (2018) Antoni Szczepanik et al. Gastric Cancer
- Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
- (2018) De-Shen Wang et al. GUT
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- (2017) Rui-hua Xu et al. NATURE MATERIALS
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer
- (2017) Hwa Mi Kang et al. PLoS One
- Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
- (2017) Yuji Mishima et al. Targeted Oncology
- Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer
- (2017) Hsiao-Wei Kao et al. Oncotarget
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
- (2016) Yilin Li et al. BRITISH JOURNAL OF CANCER
- Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer
- (2016) Yilin Li et al. Chinese Journal of Cancer Research
- Long-term prognostic impact of circulating tumour cells in gastric cancer patients
- (2016) Hiroaki Ito et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer
- (2016) Toru Watanabe et al. Oncology Letters
- Aberrant methylation ofPCDH10andRASSF1Agenes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer
- (2016) Charinya Pimson et al. PeerJ
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
- (2015) Myron G. Best et al. CANCER CELL
- Prognostic value of circulating CD133+cells in patients with gastric cancer
- (2015) Pu Xia et al. CELL PROLIFERATION
- Brain Tumor Mutations Detected in Cerebral Spinal Fluid
- (2015) W. Pan et al. CLINICAL CHEMISTRY
- Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients
- (2015) I. Balgkouranidou et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- The biology of circulating tumor cells
- (2015) K Pantel et al. ONCOGENE
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
- (2015) Yuxuan Wang et al. Science Translational Medicine
- Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response
- (2015) Ting-Ting Li WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer
- (2015) E. L. Kwak et al. Cancer Discovery
- MethylatedTIMP-3DNA in Body Fluids Is an Independent Prognostic Factor for Gastric Cancer
- (2014) Jiang-Liu Yu et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer
- (2014) Yongfu Shao et al. CANCER
- Circulating Methylated MINT2 Promoter DNA Is a Potential Poor Prognostic Factor in Gastric Cancer
- (2014) Jing Han et al. DIGESTIVE DISEASES AND SCIENCES
- Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta-analysis
- (2014) Xuanzhang Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies
- (2014) J. J. Luke et al. JNCI-Journal of the National Cancer Institute
- Detecting cancer by monitoring circulating tumor DNA
- (2014) Paul T Spellman et al. NATURE MEDICINE
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
- (2014) Kyongchol Kim et al. Annals of Surgical Treatment and Research
- Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer
- (2013) Long Cui et al. CANCER
- Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
- (2013) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Gastric juice miR-129 as a potential biomarker for screening gastric cancer
- (2013) Xing Yu et al. MEDICAL ONCOLOGY
- Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
- (2013) Zhi-Qiang Ling et al. PLoS One
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
- (2011) J.- Y. Pierga et al. ANNALS OF ONCOLOGY
- Blood platelets contain tumor-derived RNA biomarkers
- (2011) R. J. A. Nilsson et al. BLOOD
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- (2010) Satoshi Matsusaka et al. CANCER SCIENCE
- Significant Downregulation of Platelet Gene Expression in Metastatic Lung Cancer
- (2010) David C. Calverley et al. CTS-Clinical and Translational Science
- Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes
- (2009) Yoshiyuki Watanabe et al. GASTROENTEROLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started